Key Highlights

  • KBR trades in the same session it released second-quarter results. On the 126.79 million shares disclosed on its latest quarterly cover page, that values the Houston engineering and government services group at about US$4.4bn.
  • All figures are for the 13 weeks unless stated. Group revenue was US$2.0bn, up 2%; operating income fell 11% to US$172m, an 8.7% margin.
  • A record US$5.5bn backlog at 1.5x book-to-bill points to years of licensing and engineering work in ammonia and sustainable aviation fuel, where KBR holds named proprietary technologies rather than competing on price.
  • Orders in the segment being spun off are shrinking. A 0.8x book-to-bill means the unit consumed backlog faster than it replaced it, and the fix depends on protest rulings made by government adjudicators, not by KBR.

Why the market is paying attention

KBR trades in the same session it released second-quarter results. On the 126.79 million shares disclosed on its latest quarterly cover page, that values the Houston engineering and government services group at about US$4.4bn.

The numbers were not obviously poor. Revenue for the quarter ended rose 2% to US$2.0bn, adjusted EBITDA 7% to US$258m and adjusted earnings per share 9% to US$0.99.

What changed was the calendar and the name. The separation of Mission Technology Solutions, announced, is now targeted for, and the new company will be called Trinzic. In February KBR (NYSE:KBR) was still guiding to the second half of 2026.

What the company does

KBR runs two segments with very different economics. Mission Technology Solutions sells scientific, engineering, digital and mission-support services to governments, the Department of War, NASA and the intelligence community in the US, plus allied defence ministries. It produced about US$5.6bn of FY2025 revenue.

Sustainable Technology Solutions is smaller and more profitable, licensing proprietary process technologies and selling engineering into ammonia, sustainable aviation fuel and plastics recycling. July selections included its PureSAF technology for a Latvian plant.

The margin gap is the argument for splitting them: in FY2025 the technology arm earned a 22.5% adjusted EBITDA margin, the government arm 10.4%.

Latest financial and operating performance

All figures are for the 13 weeks unless stated. Group revenue was US$2.0bn, up 2%; operating income fell 11% to US$172m, an 8.7% margin. Net income attributable to KBR rose 32% to US$96m and diluted earnings per share 34% to US$0.75, though that mostly reflects the absence of prior-year discontinued-operations losses.

Government services revenue slipped 2% to US$1,308m as European Command contingency work ran off, having contributed US$59m a year earlier; adjusted EBITDA still rose 16% to US$158m, a 12.1% margin. Technology revenue grew 10% to US$676m, but adjusted EBITDA fell 8% to US$123m.

Backlog and options stood at US$23.0bn, with a group book-to-bill ratio, new orders against revenue burned, of 1.1x. The technology arm hit a record US$5.5bn at 1.5x; government services booked only 0.8x against US$17.5bn. Another US$10.6bn of awarded work sits outside backlog because rivals have protested it, including the National Science Foundation's 20-year Antarctic support contract.

Cash conversion is the soft spot. Operating cash flow from continuing operations fell 77% to US$50m in the quarter, and US$160m for the half against adjusted full-year guidance of US$560m-US$600m. Cash was US$312m, total debt US$2,552m and net leverage 2.3x. Guidance was reaffirmed at US$980m-US$1,040m of adjusted EBITDA; buybacks slowed to US$29m in the half from US$329m in FY2025.

The separation: what has actually been announced

This is a spin-off, not a sale. KBR intends to distribute Mission Technology Solutions to its own shareholders as a separate US-listed company, structured to be tax-free for federal income tax purposes and subject to board approval. Michael LaRouche was named chief executive-designate.

The costs already run through the accounts: KBR added back US$33m of spin-off, acquisition and restructuring costs in its second-quarter adjusted EBITDA bridge, worth US$0.19 of the US$0.99 adjusted EPS, and roughly US$46m across the half.

The prize is a re-rating, two pure plays might be valued on different multiples than a group carrying both. That is untested until the shares trade separately, and the cost is losing the diversification that let a strong technology order book offset a soft government one. The timetable has slipped once, and US$2.55bn of debt still has to be split.

The bull case

The technology half is performing. A record US$5.5bn backlog at 1.5x book-to-bill points to years of licensing and engineering work in ammonia and sustainable aviation fuel, where KBR holds named proprietary technologies rather than competing on price.

Government margins are improving as the mix rotates: 16% adjusted EBITDA growth on 2% lower revenue suggests the contingency work rolling off carried thinner economics. The US$10.6bn of protested awards costs nothing to hold.

On the reaffirmed guidance midpoint of US$4.05 of adjusted EPS, the 30 July close implies roughly 8.5 times this year's adjusted earnings.

The bear case and the risks

Orders in the segment being spun off are shrinking. A 0.8x book-to-bill means the unit consumed backlog faster than it replaced it, and the fix depends on protest rulings made by government adjudicators, not by KBR.

Cash conversion has deteriorated. Operating cash flow of US$50m in the quarter, down 77%, leaves roughly US$400m of the adjusted full-year target for the second half. That is also the likely reason buybacks fell to US$29m from US$329m in FY2025, a marked cut in the support KBR was giving its own shares.

Government contracting can end abruptly. US Transportation Command terminated the HomeSafe Alliance military household-goods contract, and KBR, which held 72% of that joint venture, booked a US$22m loss on disposal including US$64m of property and equipment impairments. Those operations have since ceased, so the 2026 drag is nil, but it shows how fast one customer decision can erase a programme.

Legacy matters have not closed. A Kuwaiti court awarded First Kuwaiti Trading Company US$41m in March 2026 in a dispute dating to the LogCAP III Iraq contract; KBR appealed on 1 April and has accrued nothing against it. It also holds US$22m of accruals for probable unallowable government costs. Pension exposure looks contained, the frozen UK scheme producing a net US$18m benefit in the half.

What investors should watch next

Separation milestones. Registration and distribution mechanics ahead of the target, and any further slippage.

Protest resolutions. Whether the Antarctic contract and the wider US$10.6bn of protested awards convert into reported backlog.

Book-to-bill in government services. A return above 1.0x would suggest timing rather than structural weakness; a second sub-1.0x quarter would not.

Second-half cash and buybacks. KBR needs roughly US$400m of adjusted operating cash flow to reach its range; repurchase activity is the readable signal of management confidence.

Third-quarter results this autumn, and any disclosure on how debt is split between the two companies.

Investor takeaway

The premise that KBR is restructuring holds, and it is further along than a vague strategic review: the government services segment has a name, a leadership team and a target date of. Delivery on the financials is mixed rather than broken. Profit is tracking guidance, technology backlog is at a record and government margins are improving, but government orders came in below one times revenue, cash conversion weakened sharply and buybacks have been throttled to a trickle. That explains why a reaffirmed outlook still produced a 4.34% fall on results day. The coming quarters should settle whether the discount is transition noise or something more durable.

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy, sell, or hold any security. Share prices can rise or fall, and past performance does not guarantee future results. Investors should conduct independent research and consult a licensed financial adviser before making investment decisions.